Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about BNTX
Recent news which mentions BNTX
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
BioNTech News: Why Is BNTX Stock Up Today?
March 30, 2022
Tickers
BNTX
CHWY
PFE
RIVN
Tags
Market News
PFE
Today's Market
From
InvestorPlace
5 Charts That Show Why Bristol-Myers Squibb Is a No-Brainer Buy
March 30, 2022
Tickers
ABBV
BMY
BNTX
GILD
Tags
JNJ
BMY
PFE
From
Motley Fool
Why BioNTech Shares Are Surging Today
March 30, 2022
Tickers
BNTX
PFE
Tags
BNTX
Health Care
Movers
From
Benzinga
Earnings Scheduled For March 30, 2022
March 30, 2022
Tickers
AER
AESE
AFIB
AGRX
Tags
USWS
STON
ORTX
From
Benzinga
Recap: BioNTech Q4 Earnings
March 30, 2022
Tickers
BNTX
Tags
News
BNTX
Earnings
From
Benzinga
Omicron BA.2 Variant Represents More Than 50% COVID-19 Cases, Says CDC Estimates: WSJ
March 30, 2022
Tickers
AZN
BNTX
GSK
JNJ
Tags
Biotech
General
COVID/19 Vaccine
From
Benzinga
Novavax Stock Is a Bet on Interest From Unvaccinated People
March 30, 2022
Tickers
BNTX
JNJ
MRNA
NVAX
Tags
Market News
MRNA
JNJ
From
InvestorPlace
A Peek Into The Markets: US Stock Futures Down Ahead Of GDP Report
March 30, 2022
Tickers
BABA
BNTX
FIVE
LULU
Tags
Futures
Market News
Benzinga
From
Benzinga
Why Moderna and BioNTech Were Winners Today
March 29, 2022
Tickers
BNTX
MRNA
PFE
Tags
PFE
Market News
MRNA
From
Motley Fool
FDA Authorizes Fourth Dose Of Moderna, Pfizer/BioNTech COVID-19 Vaccines For Older People
March 29, 2022
Tickers
BNTX
MRNA
PFE
Tags
COVID/19 Coronavirus
FDA
Trading Ideas
From
Benzinga
Biden Administration Proposes $82B In Spending For Future Pandemics Preparedness
March 29, 2022
Tickers
AZN
BNTX
GSK
JNJ
Tags
SNY
General
MRNA
From
Benzinga
Earnings Outlook For BioNTech
March 29, 2022
Tickers
BNTX
Tags
BNTX
BZI/EP
Benzinga
From
Benzinga
U.S. average daily deaths from COVID fall below 800 to lowest level since mid-August, and FDA allows second booster for people aged 50 and older
March 29, 2022
Tickers
BNTX
MRNA
Tags
MRNA
BNTX
From
MarketWatch
12 Health Care Stocks Moving In Monday's After-Market Session
March 28, 2022
Tickers
ADTX
AVCO
BNTX
BXRX
Tags
CRMD
DRRX
NEO
From
Benzinga
Overview Of Value Stocks In The Healthcare Sector
March 28, 2022
Tickers
BDSI
BIO
BNTX
INVA
Tags
BZI/VS
INVA
News
From
Benzinga
Are These 2 Rivals Beating Pfizer and Moderna?
March 28, 2022
Tickers
AZN
BNTX
CVAC
GSK
Tags
GSK
AZN
PFE
From
Motley Fool
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
March 27, 2022
Tickers
ADMP
AFIB
AFMD
AGRX
Tags
PHGE
LXRX
KMPH
From
Benzinga
How Pfizer's $6.7 Billion Arena Pharmaceuticals Buyout Could Work for Investors
March 26, 2022
Tickers
BMY
BNTX
PFE
Tags
BNTX
Recent Press Releases
BMY
From
Motley Fool
These 3 Stocks Aren't Large Caps Yet, but They Each Could Make $1 Billion in Sales in 2022
March 25, 2022
Tickers
BNTX
CLOV
GSK
PEN
Tags
BNTX
GSK
CLOV
From
Motley Fool
The U.S. is talking about a second round of COVID-19 booster shots, and it’s going to be even more complicated than last year
March 25, 2022
Tickers
BNTX
MRNA
PFE
Tags
PFE
MRNA
BNTX
From
MarketWatch
Why Moderna, BioNTech, and Novavax Stocks Are Tumbling Today
March 25, 2022
Tickers
BNTX
MRNA
NVAX
Tags
NVAX
MRNA
Recent Press Releases
From
Motley Fool
2 Green Flags for Pfizer's Future
March 25, 2022
Tickers
BNTX
PFE
Tags
Recent Press Releases
BNTX
PFE
From
Motley Fool
Airport-based study found first U.S. case of BA.2 subvariant of omicron in December
March 25, 2022
Tickers
BNTX
DNA
JNJ
MRNA
Tags
NVAX
XSPA
BNTX
From
MarketWatch
Why Most Kids Did Not Suffer Badly Due To COVID-19 Infection? Scientists Look To Solve Mystery: CNBC
March 24, 2022
Tickers
AZN
BNTX
GSK
JNJ
Tags
Top Stories
GSK
News
From
Benzinga
Is It Time to Buy COVID-19 Vaccine Stocks Again?
March 24, 2022
Tickers
BNTX
MRNA
NVAX
OCGN
Tags
OCGN
Market News
MRNA
From
Motley Fool
Biden Administration Contemplating Second COVID-19 Booster Shot Recommendation Within Weeks: Politico
March 23, 2022
Tickers
BNTX
MRNA
PFE
Tags
News
COVID/19 Coronavirus
PFE
From
Benzinga
Moderna's COVID-19 Vaccine Shows Neutralizing Antibody Response In Kids Under 6
March 23, 2022
Tickers
BNTX
MRNA
PFE
Tags
BNTX
Health Care
Benzinga
From
Benzinga
Is the FDA Slow-Walking Authorization of Novavax's COVID Vaccine?
March 23, 2022
Tickers
BNTX
MRNA
NVAX
PFE
Tags
BNTX
NVAX
MRNA
From
Motley Fool
FDA To Hold Advisory Committee Meeting To Discuss COVID-19 Vaccine Future Boosters
March 21, 2022
Tickers
BNTX
MRNA
PFE
Tags
COVID/19 Coronavirus
PFE
FDA
From
Benzinga
Moderna’s stock, down 60% since the summer’s delta wave, is rising again as COVID-19 cases increase
March 21, 2022
Tickers
BNTX
MRNA
PFE
SPX
Tags
BNTX
MRNA
SPX
From
MarketWatch
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today